Key clinical features commonly observed in cannabis dependence include: Strong craving or urge to use cannabis even when use is inappropriate Unsuccessful efforts to cut down or control use, often with repeated relapse Increasing priority on cannabis, with a reduction in participation in social, recreational, or occupational activities Time spent obtaining, using, or recovering from cannabis use at the expense of other responsibilities Continued use despite awareness of persistent or recurrent physical or psychological problems likely caused or exacerbated by cannabis Tolerance, where increased amounts are needed to achieve the desired effect Note: Tolerance may be present, but is not required for the uncomplicated specifier Although withdrawal, a physiological syndrome following cessation, can occur with cannabis, F12.20 is designated for cases without documented withdrawal

37 Controlled trials suggest that these agents are effective in treating tobacco dependence (Table 2), but they have a greater incidence of adverse effects and should be reserved for patients unable to quit with medications approved for smoking cessation
For starters, it increases the risk of mouth cancer, gum disease, and tooth decay
Ethically, clinicians should: Avoid minimizing the impacts of dependence Screen for comorbid disorders Ensure treatment goals align with client values and evidence-based practice Accurate diagnosis and careful documentation also support professional liability protection and service continuity